Clinical trial
Adjunctive Cannabidiol for Recovery From Opioid Study (ACROS)
NCT06940674 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjunctive Cannabidiol for Recovery From Opioid Study (ACROS)
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- June 13, 2025
- Completion date
- August 15, 2027
- Enrollment
- 450 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
opioid use disorder (oud)